XL‑protein GmbH today announced the launch of PASylANTA Therapeutics GmbH , a new Germany-based biotechnology company focused ...

This biotechnology firm leverages machine learning to design novel protein therapeutics targeting unmet medical needs.

DUBLIN--(BUSINESS WIRE)--The "Protein Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Protein Therapeutics was estimated at ...

A team led by principal investigators Bobo Dang and Ting Zhou at Westlake University/Westlake Laboratory have developed a high-throughput platform for engineering fast-acting covalent protein ...

Some drug treatments, particularly those that include high-dose protein-based therapeutics, are only available as an intravenous (IV) infusion. These protein therapeutics, which need to be delivered ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying AI to empower patients everywhere with genetic agency, today announced the launch of Dyno Psi-Phi ...

Traditional biologics manufacturing, reliant on sequential batch processing operations, faces significant limitations such as low productivity, lengthy processing times, and frequent manual ...

When proteins cause disease, the body has ways to tackle them. An emerging class of therapies that leverage a cell’s built-in systems to eliminate rogue proteins has already reached the clinic via ...

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...

Building on a prior MJFF-funded collaboration targeting LRRK2, Montara's BrainOnly™ platform now targets the mTOR pathway — exploring a class of drugs with longstanding scientific interest but a ...